EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/2016.

Slides:



Advertisements
Similar presentations
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Advertisements

April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Biostatistics ~ Types of Studies. Research classifications Observational vs. Experimental Observational – researcher collects info on attributes or measurements.
Main Points to be Covered
BIOST 536 Lecture 3 1 Lecture 3 – Overview of study designs Prospective/retrospective  Prospective cohort study: Subjects followed; data collection in.
Introduction to Survival Analysis Seminar in Statistics 1 Presented by: Stefan Bauer, Stephan Hemri
Cohort Studies.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
COHORT AND CASE-CONTROL DESIGNS Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa SUMMER COURSE: INTRODUCTION TO EPIDEMIOLOGY.
Use of epidemiologic methods in disaster management Dr AA Abubakar Dept of Community Medicine Ahmadu Bello University Zaria Nigeria.
Dr K N Prasad MD., DNB Community Medicine
01/20141 EPI 5344: Survival Analysis in Epidemiology Quick Review and Intro to Smoothing Methods March 4, 2014 Dr. N. Birkett, Department of Epidemiology.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma Thompson C et al. Proc ASCO 2013;Abstract 8504.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
G Lecture 121 Analysis of Time to Event Survival Analysis Language Example of time to high anxiety Discrete survival analysis through logistic regression.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
Prevalence The presence (proportion) of disease or condition in a population (generally irrespective of the duration of the disease) Prevalence: Quantifies.
Bias Defined as any systematic error in a study that results in an incorrect estimate of association between exposure and risk of disease. To err is human.
01/20151 EPI 5344: Survival Analysis in Epidemiology Interpretation of Models March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive.
01/20151 EPI 5344: Survival Analysis in Epidemiology Age as time scale March 31, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
INTRODUCTION TO SURVIVAL ANALYSIS
01/20151 EPI 5344: Survival Analysis in Epidemiology Time varying covariates March 24, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive.
01/20151 EPI 5344: Survival Analysis in Epidemiology Epi Methods: why does ID involve person-time? March 10, 2015 Dr. N. Birkett, School of Epidemiology,
01/20141 EPI 5344: Survival Analysis in Epidemiology Epi Methods: why does ID involve person-time? March 13, 2014 Dr. N. Birkett, Department of Epidemiology.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
Measuring the Occurrence of Disease 1 Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
1 1 Using Marginal Structural Model to Estimate and Adjust for Causal Effect of Post- discontinuation Chemotherapy on Survival in Cancer Trials Y. Wang,
HSRP 734: Advanced Statistical Methods July 31, 2008.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
03/20131 EPI 5344: Survival Analysis in Epidemiology Risk Set Analysis Approaches April 16, 2013 Dr. N. Birkett, Department of Epidemiology & Community.
Rates, Ratios and Proportions and Measures of Disease Frequency
THRio Antonio G F Pacheco. THRioOutline –Database setup Creating a master table with main outcomes –Mortality recovery with linkage Issues and differences.
Design and Analysis of Clinical Study 10. Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
12/20091 EPI 5240: Introduction to Epidemiology Incidence and survival December 7, 2009 Dr. N. Birkett, Department of Epidemiology & Community Medicine,
Measures of Disease Frequency
Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)
Satistics 2621 Statistics 262: Intermediate Biostatistics Jonathan Taylor and Kristin Cobb April 20, 2004: Introduction to Survival Analysis.
01/20151 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 24, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
01/20151 EPI 5344: Survival Analysis in Epidemiology Quick Review from Session #1 March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health &
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
01/20151 EPI 5344: Survival Analysis in Epidemiology Hazard March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
Analytical Studies Case – Control Studies By Dr. Sameh Zaytoun (MBBch, DPH, DM, FRCP(Manch), DTM&H(UK),Dr.PH) University of Alexandria - Egypt Consultant.
01/20141 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models April 1, 2014 Dr. N. Birkett, Department of Epidemiology & Community.
III. Measures of Morbidity: Morbid means disease. Morbidity is an important part of community health. It gives an idea about disease status in that community.
02/20161 EPI 5344: Survival Analysis in Epidemiology Hazard March 8, 2016 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine,
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
03/20161 EPI 5344: Survival Analysis in Epidemiology Estimating S(t) from Cox models March 29, 2016 Dr. N. Birkett, School of Epidemiology, Public Health.
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
03/20161 EPI 5344: Survival Analysis in Epidemiology Testing the Proportional Hazard Assumption April 5, 2016 Dr. N. Birkett, School of Epidemiology, Public.
April 18 Intro to survival analysis Le 11.1 – 11.2
Present: Disease Past: Exposure
Biostatistics Case Studies 2016
Cox Regression Model Under Dependent Truncation
Epidemiology MPH 531 Analytic Epidemiology Case control studies
Chapter 4 SURVIVAL AND LIFE TABLES
Kaplan-Meier survival curves and the log rank test
Presentation transcript:

EPI 5344: Survival Analysis in Epidemiology Week 6 Dr. N. Birkett, School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa 03/ Left Truncation

Let’s start with a boring definition Subject being ‘under observation’ at time ‘t’ means: If subject had an event at time ‘t’, then subject would have been recorded with an event in the study. 03/2016 2

What is left truncation? A selection process which affects subjects so that their event time can not be lower than some time. Can occur in two ways Subject has event between time of eligibility and entry into observation Generally ‘unknown’ to cohort Subject has period of time from eligibility to start of observation when they have to be event free since they were selected at start of observation period 03/2016 3

What is left truncation? Subjects enter study at time ‘t 0 ’ During the time interval t 0  t 1, subject is not under observation Any event during this interval is missed Time of event for this subject is truncated Can not be earlier than t 1 03/2016 4

In fact, you often know nothing about the subject If the event is ’death’, they die without you ever knowing they exist Left truncation is a subject selection issue Subjects are selected for study based on events which happen after date of eligibility 03/2016 5

Example 1 Target population MDs who had service obligations in community health centers (to pay off loans) Interested in grads from 1988 on Goal is to find out if they became depressed Problem: We can not get a list of graduated physicians 03/2016 6

Example 1 (cont) Subject selection process (recruitment date) All MDs who worked in clinics between Jan 1, 1990 & Sept 30, 1992 Issue: Many MDs who graduated between 1988 and 1990 worked in clinics before recruitment started 03/2016 7

8

Example 2 WHAS500 data set (used in Case Study #6) 500 people admitted to hospital with acute MI Interested in predictors of survival post MI BUT, only in people who were discharged alive from hospital Subject enters observation when they are discharged Follow-up starts on admission 03/2016 9

Example 2 (cont) If person died in hospital, they contribute no information to study If discharged alive, they contribute only after discharge. 03/

Left truncation (aka delayed entry) Subject ‘technically’ enters cohort at time ‘0’ Becomes ‘under observation’ is at later time ‘t’ Subject must be outcome free at this time If they had an event prior to this time, they never make it into the follow-up dataset Distribution of survival times is ‘truncated’ or ‘cut-off’ in the left tail 03/

Left truncation is more common when time scale is age Risk set is people of the same age People enter study at different ages Time ‘0’ is basically birth No information on outcomes from birth to age at entry AKA: Delayed entry 03/

Two ways of recruiting which give left truncation Prospective Recruit at time of eligibility (e.g.. diagnosis of cancer) Start observing after some future event (e.g. discharge from hospital). 03/

Two ways of recruiting which give left truncation (cont) Retrospective Identify subjects at time of some event in the future on the clinical or personal time line People discharged from hospital Determine eligibility by retrospective data collection Main difference is that truncated people never get identified by study in retrospective method 03/

Example 3 Study recruits 3,000 people discharged from hospital with history of heart disease Follow for two years to examine predictors of death But, age at diagnosis (eligibility) was up to 40 years earlier 03/

03/ Two potential time ‘0’ points for standard analyses Date of CHD Dx Date of recruitment Death What to use as time ‘0’? Date of recruitment Date of Dx Both have problems

Suppose we use: Time ‘0’ = date of initial Dx We estimate survival from initial Dx S(t) is biased People with Dx prior to recruitment to study must have h(t) = 0 Immortal person time S(t) is an average of the ‘0’ hazard and the actual hazard. 03/

Suppose we use: Time ‘0’ = date of recruitment to study Measures survival post recruitment Ignores history prior to recruitment. Recruited groups contains people with varying pre- recruitment time with heart disease. All must have survived from Dx to recruitment date 03/

Time ‘0’ = date of recruitment to study (cont) S(t) is biased People with longer pre-recruitment Dx are in a more advanced stage of their follow-up Don’t represent survival experience for the period immediately after a person’s Dx S(t) is an average of different survival experiences at different points of post-Dx time/experience. 03/

03/

2 Solutions which give unbiased estimates Exclude patients from the study sample who were diagnosed prior to recruitment Date of recruitment = date of Dx  unbiased S(t) measure Causes a major drop in sample size 03/

2 Solutions which give unbiased estimates Use an inception cohort Recruit people into study at date of Dx. Can be done prospectively But, can also do this ‘historically’ Define an entry date some time in the past Identify all newly diagnosed case after that date Determine predictors and outcomes Works best with a registry (e.g. cancer) 03/

No analytic method can recover information on events during the truncation period If we can ignore this, solution is ‘easy’ Set the ‘immortal person-time’ as outside the period of follow-up. Subjects have ‘delayed entry’ into study Assumes that the hazard starting from the time of recruitment is unaffected by the delayed entry 03/

Two approaches can be used in SAS. Define a delayed entry or truncation time variable Add a command to the Model statement giving entry time to risk set 03/

Two approaches can be used in SAS (cont) Use the Counting process input style Only one interval From entry time to end of study Need to specify (for each subject): Start of their follow-up time End of their follow-up time Outcome status (event vs. censored) No need to do any data re-structuring in this case 03/

Example #2 (cont) Want to estimate predictors of survival from time of MI for people who are discharged alive from hospital People dying in hospital are left truncated 03/

Example #2 (cont) Data set has a variable (LOS) which is the number of days in hospital Method 1: Add LOS to model statement as ‘entrytime’ Method 2: No need to rearrange data only one interval per subject starts at ‘LOS’ ends at study time 03/

03/ proc phreg data = whas500A; model lenfol*fstat(0) = bmifp1 bmifp2 age hr diasbp gender chf age*gender/; run; proc phreg data = whas500A; model lenfol*fstat(0) = bmifp1 bmifp2 age hr diasbp gender chf age*gender/ entrytime = los; run; proc phreg data = whas500A; model (los,lenfol)*fstat(0) = bmifp1 bmifp2 age hr diasbp gender chf age*gender; run;

03/ Ignores late entry

03/ Late entry, method #1

03/ Late entry, method #2